Do it right. Do it better.

Beating cancer isn't easy. Neither is running a clinical trial. We need to do it right and do it better. 

At the Dana-Farber/Harvard Cancer Center, our investigators are renowned for cutting-edge and ground-breaking science. The ODQ brings that same innovative spirit to clinical research quality and operations. 

Let's move research forward. The fight against cancer is too important not to.

ODQ News & Updates

  • August 16, 2019 – PRMS

    Emails generated within iRIS are now working! Thank you all for your patience. If you continue to experience issues with not receiving emails, please enter a helpdesk ticket.

  • August 16, 2019 – PRMS

    Some users are experiencing issues related to amendments requiring operational readiness and sub-site amendment feasibility. The support team is currently looking for a resolution. Please see the below descriptions and...

  • August 16, 2019 – PRMS

    Study Team Members and Investigators should read the following article to avoid delays in processing with regards to Investigator Attestation Forms.

Most Accessed Documents

  • Link
  • Link
  • Link
  • Link
  • Link